US 10933076
Crocin-sorafenib combination therapy for liver cancer
granted A61KA61K31/44A61K31/7024
Quick answer
US patent 10933076 (Crocin-sorafenib combination therapy for liver cancer) held by UNITED ARAB EMIRATES UNIVERSITY expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- UNITED ARAB EMIRATES UNIVERSITY
- Grant date
- Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/44, A61K31/7024, A61P, A61P35/00